| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0045 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |